Etiology, diagnosis, and management of pneumonia in immunosuppressed patients

Salavert Lletí, Miguel; Cabañero Navalón, Marta Dafne; Tasias Pitarch, Mariona; García-Bustos, Víctor.
Rev. esp. quimioter ; 35(supl. 1): 89-96, abr. - mayo 2022. ilus, tab
Artículo en Inglés | IBECS (España) | ID: ibc-205356

Documentos relacionados

  1. Novel approaches to the prediction and diagnosis of pulmonary complications in the paediatric haematopoietic stem cell transplant patient.
  2. Role of specialized pro-resolving lipid mediators in pulmonary inflammation diseases: mechanisms and development.
  3. [How to handle a non-resolving pneumonia?]
  4. Evaluation of pulmonary abnormalities in recipients of hematopoietic cell transplants and cellular therapies.
  5. Pharmacokinetics and Adverse Effects of Clofazimine in the Treatment of Pulmonary Non-Tuberculous Mycobacterial Infection.
  6. Disease Progression in Patients With Nontuberculous Mycobacterial Lung Disease of Nodular Bronchiectatic (NB) Pattern: The Roles of Cavitary NB and Soluble Programmed Death Protein-1.
  7. The role of flexible bronchoscopy in the diagnostic pathway of children with unexplained peripheral eosinophilia.
  8. Early-life pulmonary viral infection leads to long-term functional and lower airway structural changes in the lungs.
  9. Vancomycin-Induced Organizing Pneumonia: A Case Report and Literature Review.
  10. [The differential diagnosis for novel coronavirus pneumonia and similar lung diseases in general hospitals].